ネクセラファーマ(株)【4565】の掲示板 2016/02/09
-
1284
ＭＲＴ保険適用 国からの助成金♥
強く買いたい
2016年2月9日 20:51
>>1280
> 英語の原文をよく読みましょう
> 上市されたところです
> そーせいからも発表があるでしょう
>
> Drug Product Name:UTIBRON NEOHALER Rx
> UTIBRON NEOHALER
> Pharmacological Class:
> Long-acting beta2-agonist (LABA) + anticholinergic.
>
> Active Ingredient(s):
> Indacaterol 27.5mcg, glycopyrrolate 15.6mcg; per capsule; dry powder for oral inhalation for use with Neohaler device; contains lactose.
>
> Company
> Novartis Pharmaceuticals Corp
>
> Indication(s):
> Long-term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema. Limitations of use: not for the relief of acute bronchospasm or for the treatment of asthma.
>
> 途中略
>
> LAST UPDATED:
> 2/8/2016
出たようですねこれ
ぎょえ～
三ヽ(;´Д`)ノ
三 ( )
三 ノ >
英語の原文をよく読みましょう
上市されたところです
そーせいからも発表があるでしょう
Drug Product Name:UTIBRON NEOHALER Rx
UTIBRON NEOHALER
Pharmacological Class:
Long-acting beta2-agonist (LABA) + anticholinergic.
Active Ingredient(s):
Indacaterol 27.5mcg, glycopyrrolate 15.6mcg; per capsule; dry powder for oral inhalation for use with Neohaler device; contains lactose.
Company
Novartis Pharmaceuticals Corp
Indication(s):
Long-term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema. Limitations of use: not for the relief of acute bronchospasm or for the treatment of asthma.
途中略
LAST UPDATED:
2/8/2016